Stay away from Sun Pharma, Bharti Airtel, say experts

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Prakash Diwan, Altamount Capital Management and Dipan Mehta, member BSE & NSE shared in an interview to CNBC-TV18 recommended stocks that one could look at or ignore. Both of them were bearish on Sun Pharma would not be a great investment currently and it would be better to wait and watch. Dipan said things seemed to be getting murkier for the company and it is likely to be under stress not only for the current financial year but also FY16-17. He recommended lightening positions on the stock and is likely to fall more than 10 percent in coming days. Diwan said people were expecting a resurrection of Ranbaxy but the Sun management till date has not given a proper timeline and so it is better to keep away from it for some time.When asked if it was time to add exposure into Bharti Airtel, both again were skeptical and said it will now have to brace itself for strong competition from Reliance Jio. Most of the telecom companies would now to beef up their resources, said Mehta. He is currently underweight on the sector. Diwan said telecom will get re-rated after Reliance Jio enters and so it would be advisable to wait. Recommending some individual stocks, Dipan said LIC Housing Finance was the best performer in the non-banking and financial company (NBFC) sapce and could see a growth of around 50 percent in the next 4-5 years. He liked the space because the non-performing assets (NPAs) for them are under control. According to Diwan Asahi India, which is in the automotive space is slated to be a multi-bagger and has a good pedigree. The company is into all aspects of glass. There is also lot of institutional interest in the stock, he added. He also recommends Shemaroo Entertainment. For the entire interview watch video